Literature DB >> 27520547

Dual roles of CCN proteins in breast cancer progression.

Celina G Kleer1.   

Abstract

The tumor microenvironment has a powerful effect on the development and progression of human breast cancer, which may be used therapeutically. Despite efforts to understand the complex role of the tumor microenvironment in breast cancer development, the specific players and their contributions to tumorigenesis need further investigation. The CCN family of matricellular proteins comprises six members (CCN1-6; CYR61, CTGF, NOV, WISP1-3) with central roles in development, inflammation, and tissue repair. CCN proteins also exert functions during pathological processes including fibrosis and cancer by regulating extracellular signals in the cellular environment. Studies have demonstrated that all six CCN proteins exert functions in breast tumorigenesis. Although CCN proteins share a multimodular structure in which most cysteine residues are conserved within structural motifs, they may have opposing functions in breast cancer progression. A better understanding of the functions of each CCN member will assist in the development of specific therapeutic approaches for breast cancer.

Entities:  

Keywords:  Breast cancer; CCN; CCN6; CTGF; CYR61; Differentiation; Matricellular; Metastasis; NOV; Stem cells; WISP1; WISP2; WISP3

Year:  2016        PMID: 27520547      PMCID: PMC5055502          DOI: 10.1007/s12079-016-0345-7

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  52 in total

Review 1.  NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues.

Authors:  B Perbal
Journal:  Mol Pathol       Date:  2001-04

2.  Identification of rCop-1, a new member of the CCN protein family, as a negative regulator for cell transformation.

Authors:  R Zhang; L Averboukh; W Zhu; H Zhang; H Jo; P J Dempsey; R J Coffey; A B Pardee; P Liang
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

3.  Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis.

Authors:  Wenwen Chien; James O'Kelly; Daning Lu; Amanda Leiter; Julia Sohn; Dong Yin; Beth Karlan; Jay Vadgama; Karen M Lyons; H Phillip Koeffler
Journal:  Int J Oncol       Date:  2011-03-23       Impact factor: 5.650

4.  CCN5/WISP-2 promotes growth arrest of triple-negative breast cancer cells through accumulation and trafficking of p27(Kip1) via Skp2 and FOXO3a regulation.

Authors:  I Haque; S Banerjee; A De; G Maity; S Sarkar; M Majumdar; S S Jha; D McGragor; S K Banerjee
Journal:  Oncogene       Date:  2014-08-18       Impact factor: 9.867

5.  Identification of TACC1, NOV, and PTTG1 as new candidate genes associated with endocrine therapy resistance in breast cancer.

Authors:  Sandra E Ghayad; Julie A Vendrell; Ivan Bieche; Frédérique Spyratos; Charles Dumontet; Isabelle Treilleux; Rosette Lidereau; Pascale A Cohen
Journal:  J Mol Endocrinol       Date:  2008-11-04       Impact factor: 5.098

6.  WISP3 (CCN6) is a secreted tumor-suppressor protein that modulates IGF signaling in inflammatory breast cancer.

Authors:  Celina G Kleer; Yanhong Zhang; Quintin Pan; Sofia D Merajver
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

7.  Matricellular protein CCN3 (NOV) regulates actin cytoskeleton reorganization.

Authors:  Wun-Chey Sin; Mimi Tse; Nathalie Planque; Bernard Perbal; Paul D Lampe; Christian C Naus
Journal:  J Biol Chem       Date:  2009-08-25       Impact factor: 5.157

8.  CCN5/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells.

Authors:  Snigdha Banerjee; Gopal Dhar; Inamul Haque; Suman Kambhampati; Smita Mehta; Krishanu Sengupta; Ossama Tawfik; Teresa A Phillips; Sushanta K Banerjee
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

9.  Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1.

Authors:  P Bornstein
Journal:  J Cell Biol       Date:  1995-08       Impact factor: 10.539

10.  Cyr61 as mediator of Src signaling in triple negative breast cancer cells.

Authors:  María Pilar Sánchez-Bailón; Annarica Calcabrini; Víctor Mayoral-Varo; Agnese Molinari; Kay-Uwe Wagner; Jesús Pérez Losada; Sergio Ciordia; Juan Pablo Albar; Jorge Martín-Pérez
Journal:  Oncotarget       Date:  2015-05-30
View more
  10 in total

1.  In Vitro Validation of the Hippo Pathway as a Pharmacological Target for Canine Mammary Gland Tumors.

Authors:  Samantha Guillemette; Charlène Rico; Philippe Godin; Derek Boerboom; Marilène Paquet
Journal:  J Mammary Gland Biol Neoplasia       Date:  2017-08-18       Impact factor: 2.673

Review 2.  The matricellular protein CCN1 in tissue injury repair.

Authors:  Ki-Hyun Kim; Jong Hoon Won; Naiyuan Cheng; Lester F Lau
Journal:  J Cell Commun Signal       Date:  2018-01-22       Impact factor: 5.782

Review 3.  Matricellular CCN6 (WISP3) protein: a tumor suppressor for mammary metaplastic carcinomas.

Authors:  Mai N Tran; Celina G Kleer
Journal:  J Cell Commun Signal       Date:  2018-01-22       Impact factor: 5.782

4.  Fine-tuning the metabolic rewiring and adaptation of translational machinery during an epithelial-mesenchymal transition in breast cancer cells.

Authors:  Tamara Fernández-Calero; Marcos Davyt; Karen Perelmuter; Cora Chalar; Giovana Bampi; Helena Persson; Juan Pablo Tosar; Völundur Hafstað; Hugo Naya; Carlos Rovira; Mariela Bollati-Fogolín; Ricardo Ehrlich; Gilles Flouriot; Zoya Ignatova; Mónica Marín
Journal:  Cancer Metab       Date:  2020-07-19

Review 5.  An early history of CCN2/CTGF research: the road to CCN2 via hcs24, ctgf, ecogenin, and regenerin.

Authors:  Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2017-10-26       Impact factor: 5.782

6.  Ultrasound microbubble-mediated RNA interference targeting WNT1 inducible signaling pathway protein 1(WISP1) suppresses the proliferation and metastasis of breast cancer cells.

Authors:  Faying Fang; Weizhi Xu; Jian Zhang; Jin Gu; Gaoyi Yang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 7.  The role of CCN4/WISP-1 in the cancerous phenotype.

Authors:  Mary P Nivison; Kathryn E Meier
Journal:  Cancer Manag Res       Date:  2018-08-27       Impact factor: 3.989

Review 8.  The emerging role of WISP proteins in tumorigenesis and cancer therapy.

Authors:  Yi Liu; Yizuo Song; Miaomiao Ye; Xiaoli Hu; Z Peter Wang; Xueqiong Zhu
Journal:  J Transl Med       Date:  2019-01-16       Impact factor: 5.531

9.  Scutellarin Ameliorates Renal Injury via Increasing CCN1 Expression and Suppressing NLRP3 Inflammasome Activation in Hyperuricemic Mice.

Authors:  Guozheng Li; Chen Guan; Lingyu Xu; Lin Wang; Chengyu Yang; Long Zhao; Bin Zhou; Congjuan Luo; Hong Luan; Wei Jiang; Chenyu Li; Yan Xu
Journal:  Front Pharmacol       Date:  2020-10-22       Impact factor: 5.810

Review 10.  Potential Role of CCN Proteins in Breast Cancer: Therapeutic Advances and Perspectives.

Authors:  Kazi Ahsan Ahmed; Tasnin Al Hasib; Shamrat Kumar Paul; Md Saddam; Afsana Mimi; Abu Saim Mohammad Saikat; Hasan Al Faruque; Md Ataur Rahman; Md Jamal Uddin; Bonglee Kim
Journal:  Curr Oncol       Date:  2021-11-26       Impact factor: 3.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.